# Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)

> **NCT06180070** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 36 (actual)

## Conditions studied

- Migraine
- Headache
- Backache

## Interventions

- **DRUG:** Ibuprofen/ Paracetamol tablets
- **DRUG:** Nuromol® tablets

## Key facts

- **NCT ID:** NCT06180070
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-29
- **Primary completion:** 2023-09-14
- **Final completion:** 2023-10-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06180070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06180070, "Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06180070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*